LXQ46
LXQ46 is a potent, orally bioavailable PTP1B inhibitor (IC50 = 0.190 μM) that enhances insulin and leptin signaling in insulin-resistant C2C12 cells. It has demonstrated efficacy in improving metabolic parameters in mouse models of type 2 diabetes, making it a valuable research tool for studying insulin resistance and obesity-related pathways.
Product Specifications
CAS Number
2097148-94-0
Field of Research
Metabolism Research
Smiles
BrC=1C (Br) =C (C=C (O) C1O) C2=NC=C (O2) C=3C=CC (OC4=CC=C (OCC) C=C4) =CC3
Molecular Formula
C23H17Br2NO5
Molecular Weight
547.19
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
bsm-62351R-Cy7-TR 20 µL
Kir2.1 Recombinant Antibody, Cy7 Conjugated
Sign In for Pricing
View Details